Quantapore Inc. is a biotechnology company focused on the development of an ultra-low-cost, high-throughput DNA sequencing platform. Based in Menlo Park, CA, the company was founded in 2009 and is well on its way to the commercialization of its novel sequencing platform. The combination of low cost, long reads, simple workflow and fast sample-to-results turnaround time holds the promise to make Quantapore Inc. one of the world's leading sequencing system providers.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/19/18 | $15,500,000 | Series 3 |
Baidu Ventures Cloudstone Venture Northern Light Venture Capital  Sangel Venture Capital Tsingyuan Ventures | undisclosed |
